VAERS reports by lot

Seqirus / CSL Flu lot 195216: VAERS reports

23 VAERS reports list lot 195216 as a Seqirus / CSL Flu vaccine, received between 2017-09-13 and 2019-09-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
13%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1827%
Dermatological (non-injection-site)1218%
General / Systemic (non-local)1015%
Neurological812%
Allergic / Anaphylactic710%
Musculoskeletal46%
Cardiac / Cardiovascular23%
Respiratory23%
Gastrointestinal23%
Psychiatric / Neuropsychiatric11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 9).

North Carolina2
Florida2
Alaska1
California1
Montana1
Colorado1
Pennsylvania1
Washington1
Utah1

Reports by month received

2017-093
2017-103
2017-111
2018-018
2018-031
2019-016
2019-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.